Chicagoland Peptides products are Research Use Only ("RUO") and are intended solely for basic research, pharmaceutical research, laboratory experimentation, or the development of new tests — not for diagnosing, treating, curing, or preventing any disease or condition in any patient. These statements have not been evaluated by the U.S. Food and Drug Administration.
Epithalon (Epitalon) and Telomere Research: What the Published Cell Studies Report
Last reviewed: September 16, 2026
Epithalon (also written Epitalon) is the synthetic tetrapeptide Ala-Glu-Asp-Gly, and the published literature most frequently associated with it concerns telomerase and telomere length in cultured human cells [1]. In an in vitro experiment, addition of the peptide to telomerase-negative human fetal fibroblast cultures was reported to induce expression of the catalytic subunit of telomerase, enzymatic telomerase activity, and elongation of telomeres [1]. The authors interpreted this as possible reactivation of the telomerase gene in somatic cells and framed it as an indication that the lifespan of a cell population might be extendable, a hypothesis stated at the level of cell culture rather than demonstrated in an organism [1].
A follow-up in vitro study from the same group examined proliferative potential rather than telomerase expression alone [2]. Primary pulmonary fibroblasts derived from a 24-week human fetus lost proliferative potential at the 34th passage, and mean telomere length in those late-passage cells was appreciably lower than at passage 10 [2]. When Epithalon was added to the aging cultures, the investigators reported telomere elongation to a length comparable with that seen at early passages, and peptide-treated cells underwent approximately 10 additional divisions relative to control cultures, reaching passage 44 and continuing to divide [2]. The authors described this as the cultures overcoming the Hayflick limit under the conditions tested [2].
Two constraints are important when reading this literature. First, both findings are from cell culture using human fetal fibroblasts, so they describe cellular behaviour in vitro and are not human clinical results [1][2]. Second, the two reports come from the same research group and share the same experimental model, so the retrieved evidence base for the telomere-related observations is narrow rather than independently replicated across laboratories [1][2]. Researchers evaluating Epithalon in telomere biology should note that the cited work characterises telomerase subunit expression, telomerase activity, telomere length, and passage number as measured endpoints [1][2].
In plain terms
Epithalon, also spelled Epitalon, is a short four-amino-acid peptide (Ala-Glu-Asp-Gly). The studies retrieved here were done in cells in a dish — specifically human fetal lung fibroblasts — not in animals and not in people [1][2].
In one cell study, adding the peptide to cells that normally make no telomerase was reported to switch on the telomerase catalytic subunit, produce telomerase activity, and lengthen telomeres [1]. In a second cell study by the same group, old cultures that had stopped dividing at passage 34 showed telomere lengthening back toward early-passage lengths after the peptide was added, and those cultures went through about 10 more divisions than untreated cultures before the experiment ended [2].
Both reports come from the same laboratory and the same type of cell model, so they are a small and not independently repeated body of work [1][2]. Nothing in this set of studies measured outcomes in living animals or humans [1][2].
Related products
References
- Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.. Bull Exp Biol Med. 2003. (in vitro) PubMed
- Khavinson VKh, Bondarev IE, Butyugov AA, Smirnova TD. Peptide promotes overcoming of the division limit in human somatic cell.. Bull Exp Biol Med. 2004. (in vitro) PubMed
